News & Insights for Healthcare Professionals - Medthority

This site is intended for healthcare professionals

Follow the latest in healthcare trends and news!

Latest News

Abbott initiates clinical study to evaluate the use of its deep brain stimulation system to manage severe depression.

2 mins

Positive results from phase III trial of Nucala (mepolizumab) announced in COPD.-GSK

1 mins

Roche presents new 48-week data for the Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib from the phase II FENopta open-label extension (OLE) study at the ECTRIMS conference.

2 mins

Presentation at European Society of Cardiology demonstrates VIVO accuracy in complex ventricular tachycardia patients. - Catheter Precision Inc.

1 mins

In a first-of-its-kind fixed dose study, once weekly insulin efsitora alfa leads to A1C reduction similar to daily insulin

2 mins

Bayer introduces Age Factor ecosystem

1 mins

Positive topline results from study of higher dose regimen of nusinersen, showing significant benefit in treatment of spinal muscular atrophy

2 mins

Arrowhead Pharmaceuticals presents new pivotal phase III data at ESC 2024 from PALISADE study of plozasiran in patients with familial chylomicronemia syndrome

2 mins

European Commission approves EUR Neffy (epinephrine nasal spray) for emergency treatment of severe allergic reactions in adults and children

1 mins

FDA accepts NDA for sebetralstat for oral on-demand treatment of hereditary angioedema.- KalVista Pharma

1 mins

Finerenone showed statistically significant improvement in cardiovascular outcomes in adults with common form of heart failure with high unmet medical need

3 mins

Tolebrutinib meets primary endpoint in HERCULES phase III study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis

1 mins

BridgeBio shares dData on serum TTR increase when switching participants from placebo and tafamidis to acoramidis in ATTRibute-CM and its open-label extension.- BridgeBio Pharma.

2 mins

Cytokinetics presents additional data from SEQUOIA-HCM at the European Society of Cardiology Congress 2024.

5 mins

An NDA is submitted to the FDA for TLX101-CDx, (Pixclara, 18F-floretyrosine or 18F-FET), an investigational PET agent for the characterisation of progressive or recurrent gliomas

1 mins

Spotlight Articles

Is exercise an effective treatment for Parkinson’s disease?

2 mins

ASCO 2024: A high-level overview

9 mins

Can smartwatches detect sleep apnea earlier?

3 mins

Apple’s AFib history FDA qualified for trials

3 mins

Osimertinib for EGFR-mutated NSCLC – LAURA trial

2 mins

Can telemedicine palliate patients with NSCLC?

1 mins

Clinical trial update on treatments for mCRPC

4 mins

What is the outlook for Pompe disease management?

3 mins

Racism in healthcare systems worsens outcomes for Black women

5 mins

The future of vaccination in a post-COVID-19 world

10 mins

Why do we not have vaccines for HIV and hepatitis C? An overview of current challenges

5 mins

From chickenpox to shingles: The developmental history of herpes zoster vaccines

5 mins

Challenges in the management of painful diabetic peripheral neuropathy

10 mins

Psychedelics in psychiatry – a world first in Australia

10 mins

Managing opioid prescribing in the ‘inherited’ patient with pain

10 mins

Looking under the surface of clinical trials: Are the findings valid and relevant to your patients?

20 mins

Interpreting clinical trial results through a frame of reference: Why take the time?

10 mins

How can flaws in clinical trial design, conduct and reporting impact clinical decision-making?

10 mins

Empty shelves: drug shortages in the UK

5 mins

Innovations in cancer therapy: antibody-drug conjugates

5 mins

Chronotherapy: introducing the circadian rhythms into treatment landscapes

9 mins

Vision for a better future: lessons from The Lancet Global Health Commission on Global Eye Health

5 mins

“It’s all in your head”: what long-COVID research has taught us about chronic fatigue syndrome

10 mins

Responding to requests for opioid analgesics from patients with chronic pain

10 mins

Is COVID-19 associated with increased risk of herpes zoster?

10 mins

Do HCPs need specific LGBTQ+ training?

10 mins

What is pneumonia? Education and communication between physicians

10 mins

The clinician-patient relationship, online and offline: An opportunity to contribute to improved population health outcomes

10 mins

Emergent Fungal Concerns to Human Health: A Wake-Up Call

10 mins

Abemaciclib: a newcomer in the treatment of HR+/HER2− early breast cancer

10 mins

A Gut Feeling: The Association Between Cancer and the Microbiome

5 mins

Opioid prescribing for chronic noncancer pain in general practice

5 mins

On the pulse: Smartwatches for AFib

5 mins

Selecting migraine treatments for your patient – what should you consider?

40 mins

Managing migraine over time – are anti-CGRP treatments robust in the long run?

15 mins

Anti-CGRP treatments for migraine – are they holding their promise?

20 mins

Over the horizon: early stage trials for NASH

10 mins

Phase II trials and stem cell therapies

10 mins

The next global epidemic

5 mins

The latest treatments in NASH

15 mins

The future of organ transplantation

5 mins

Complications of stem cell transplants

5 mins

Challenges in transplant organ rejection

5 mins

Treating rejection in organ transplants

10 mins

Moderate-to-severe psoriasis: the disease burden and unmet needs in different patient groups

4 mins

Antibody-drug conjugates (ADCs)

5 mins

Cancer immunotherapies

6 mins

Left ventricular assist devices – A viable therapeutic option for heart failure?

7 mins

Improving non-alcoholic steatohepatitis care – is the finishing line in sight?

6 mins

How close are we to a disease-modifying treatment for Alzheimer’s?

8 mins

Biologic efficacy for complications associated with moderate-to-severe psoriasis

4 mins

Moderate-to-severe psoriasis: treatment for young women

4 mins

Unravelling the microbiome - health through happy communities

2 mins

Part Two | New hopes for treatment in the global obesity epidemic

4 mins

Inactivity in the elderly increases their cardiovascular risk by 14%

1 mins

Type 2 diabetes risk may be increased by statin use in susceptible individuals

1 mins

Part Four | Obesity, Type 2 diabetes and cardiovascular disease: Finding the magic bullet

2 mins

Latest updates to the Chronic Spontaneous Urticaria Knowledge Centre

1 mins

Part Three | Next generation obesity therapies

2 mins

Medical cannabis - a novel approach to pain control

8 mins

Immobility and sleep disruption in the ICU - Latest recommendations

1 mins

Prof Vincent interview - Defining the eCASH Concept in PAD Management

1 mins

Appetite and the brain - white matter integrity to blame?

1 mins

Magnetic nanoparticles could help rejuvenate damaged hearts

1 mins

Long-term disease control in Psoriasis: announcing a new project

1 mins

Targeted therapies in triple negative breast cancer

4 mins

Senolytics: an emerging therapeutic for the prevention and treatment of cardiovascular disease

6 mins

Part One | The effects of obesity and the links to diabetes and cardiovascular disease: now and in the future

2 mins

Opioids - Over the horizon

2 mins

From Acne to Immunotherapy: new applications for FMT (Faecal Microbiota Transplantation)

3 mins

Horizons: a series of opinion & insight articles on disruptive healthcare in practice

1 mins

New findings may pave the way for novel HIV drugs

1 mins

Replacement therapies for opioid drugs in pain treatment

2 mins

Acute myeloid leukaemia: Hope for new treatments

6 mins

Adoptive T cell therapy, advanced melanoma and survival

1 mins

An independent review of current treatments for migraine

3 mins

Launch of LAL-Deficiency Knowledge Centre

1 mins

Migraine treatments: On the horizon

1 mins

Psoriasis Knowledge Centre relaunches on Medthority.com

1 mins

New rare disease platform launched for Hunter Syndrome

1 mins

Vitamin D in pregnancy - is it any good?

1 mins

Close social relationships may slow cognitive decline

1 mins

Microbiomes: is there nothing that they can't do?

2 mins

Reformulation of postnatal haemorrhage prophylaxis could save thousands in lower income countries

3 mins

Senolytics: Can we treat age-related diseases with a single drug

4 mins

Opioids: the future and challenging the epidemic

2 mins

Opioids: The war on drugs

5 mins

Targeted therapies in HER2 positive breast cancer

6 mins

Genetic variation and drug efficacy - could this pave the way for personalised medicines?

1 mins

Shaken not stirred your bacteriophage cocktail

3 mins

Breast Cancer- Targeted therapies

2 mins

Launch of Oral Anticoagulation Reversal Knowledge Centre

1 mins

World Congress of Dermatology 2019 - A new ERA for global Dermatology

1 mins

Nonalcoholic steatohepatitis: the next global epidemic?

5 mins

Migraine: The forgotten epidemic?

2 mins

Schizophrenia: challenges in a crowded market

8 mins

Targeted therapies in HER2 negative breast cancer

5 mins

The way ahead for cystic fibrosis

4 mins

Japan's aging population and Alzheimer's

1 mins

Learning Zones

Type 2 Inflammation in COPD

1 mins

30 mins

All Things Angioedema and Urticaria: Podcasts

30 mins

Ulcerative colitis Learning Zone

90 mins

Psoriasis Academy

910 mins

Alopecia areata Learning Zone

60 mins

1 mins

Type 2 Inflammation in Gastroenterology

160 mins

Pediatric Atopic Dermatitis

30 mins

Pompe Disease: Key findings from WMS 2022

150 mins

Supportive care in oncology Learning Zone

150 mins

Albumin in fluid management

115 mins

Antiplatelet therapy in ACS: Choices and Controversies

270 mins

Chronic Kidney Disease Learning Zone

340 mins

Inflammatory Bowel Disease Learning Zone

100 mins

CDK4/6 inhibitors in breast cancer

199 mins

Fibrinogen Deficiency in Bleeding Learning Zone

160 mins

Oral Anticoagulation Reversal Learning Zone

355 mins